Table 3.

Correlation between TERT promoter mutation status and tumor recurrence

Recurrence on follow-upNumber of patientsTERT mutation present (%)TERT mutation absent (%)P
pTa LGYes1716/17 (94%)1/17 (6.0%)0.21
(N = 28)aNo97/9 (78%)2/9 (22%)
pTa HGYes1713/17 (77%)4/17 (24%)0.14
(N = 31)aNo126/12 (50%)6/12 (50%)
CISYes117/11 (64%)4/11 (36%)0.90
(N = 17)No64/6 (67%)2/6 (33%)

Abbreviations: HG, high-grade papillary noninvasive urothelial carcinoma; LG, low-grade papillary noninvasive urothelial carcinoma; CIS, “flat” urothelial carcinoma in situ.

  • aRecurrence status was not available in 2 cases.